Kba.62 and S100 protein expression in cytologic samples of metastatic malignant melanoma

Diagnostic Cytopathology

Volumn 41, Issue 10, 2013, Pages 847-851

  Erdag, Gulsun ^a   Chowdhuri, Sinchita Roy ^a   Fetsch, Patricia ^a   Erickson, Dana ^a   Hughes, Marybeth S ^a   Filie, Armando C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

cytology; immunocytochemistry immunohistochemistry; KBA.62; melanoma; S100 protein

Indexed keywords

CYTOKERATIN AE1; CYTOKERATIN AE3; MELAN A; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY HMB 45; PROTEIN KBA.62; PROTEIN S 100; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOPATHOLOGY; EPITHELIOID CELL; EX VIVO STUDY; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MELANOMA; MELANOMA CELL; METASTATIC MELANOMA; PANCREAS; PERITONEAL FLUID; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SPINDLE CELL;

CYTOLOGY; IMMUNOCYTOCHEMISTRY/IMMUNOHISTOCHEMISTRY; KBA.62; MELANOMA; S100 PROTEIN;

ANTIBODIES, MONOCLONAL; BIOPSY, FINE-NEEDLE; CASE-CONTROL STUDIES; HUMANS; MELANOMA; MELANOMA-SPECIFIC ANTIGENS; S100 PROTEINS;

EID: 84885019474     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.22948     Document Type: Article

References (26)

1. Piao Y, Guo M, Gong Y,. Diagnostic challenges of metastatic spindle cell melanoma on fine-needle aspiration specimens. Cancer 2008; 114: 94-101.
2. Beaty MW, Fetsch P, Wilder AM, Marincola F, Abati A,. Effusion cytology of malignant melanoma. A morphologic and immunocytochemical analysis including application of the MART-1 antibody. Cancer 1997; 81: 57-63.
3. Murali R, Doubrovsky A, Watson GF, et al. Diagnosis of metastatic melanoma by fine-needle biopsy: Analysis of 2,204 cases. Am J Clin Pathol 2007; 127: 385-397.
4. Cohen-Knafo E, al Saati T, Aziza J, et al. Production and characterisation of an antimelanoma monoclonal antibody KBA.62 using a new melanoma cell line reactive on paraffin wax embedded sections. J Clin Pathol 1995; 48: 826-831.
5. Kaufmann O, Koch S, Burghardt J, Audring H, Dietel M,. Tyrosinase, melan-A, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections. Mod Pathol 1998; 11: 740-746.
6. Kocan P, Jurkovic I, Boor A, et al. Immunohistochemical study of melanocytic differentiation antigens in cutaneous malignant melanoma. A comparison of six commercial antibodies and one non-commercial antibody in nodular melanoma, superficially spreading melanoma and lentigo maligna melanoma. Cesk Patol 2004; 40: 50-56.
7. Pages C, Rochaix P, al Saati T, et al. KBA.62: A useful marker for primary and metastatic melanomas. Hum Pathol 2008; 39: 1136-1142.
8. Aung PP, Sarlomo-Rikala M, Lasota J, Lai J, Wand Z, Miettinen M,. KBA62 and PNL2: 2 new melanoma marlers-Immunohistochemical analysis of 1563 tumors including metastatic, desmoplastic, and mucosal melanomas and their mimics. Am J Surg Pathol 2012; 36: 265-272.
9. Aisner DL, Maker A, Rosenberg SA, Berman DM,. Loss of S100 antigenicity in metastatic melanoma. Hum Pathol 2005; 36: 1016-1019.
10. Nasiell K, Tani E, Skoog L,. Fine needle aspiration cytology and immunocytochemistry of metastatic melanoma. Cytopathology 1991; 2: 137-147.
11. Simmons TJ, Martin SE,. Fine-needle aspiration biopsy of malignant melanoma: A cytologic and immunocytochemical analysis. Diagn Cytopathol 1991; 7: 380-386.
12. Ikeda K, Tate G, Iezumi K, Suzuki T, Kitamura T, Mitsuya T,. Effusion cytomorphology and immunocytochemistry of malignant melanoma: Five cases of melanotic melanoma and one case of amelanotic melanoma. Diagn Cytopathol 2009; 37: 516-521.
13. Lai R, Redburn J, Nguyen GK,. Cytodiagnosis of metastatic amelanotic melanomas by fine-needle aspiration biopsy. Adjunctival value of immunocytochemistry and electron microscopy. Cancer 1998; 84: 92-97.
14. Gupta RK, Kenwright DN, Fauck R, Lallu S, Naran S,. The usefulness of a panel of immunostains in the diagnosis and differentiation of metastatic malignancies in pericardial effusions. Cytopathology 2000; 11: 312-321.
15. Hookim K, Roh MH, Willman J, et al. Application of immunocytochemistry and BRAF mutational analysis to direct smears of metastatic melanoma. Cancer Cytopathol 2012; 120: 52-61.
16. Longatto Filho A, de Carvalho LV, Santos GC, et al. Cytologic diagnosis of melanoma in serous effusions. A morphologic and immunocytochemical study. Acta Cytol 1995; 39: 481-484.
17. Fetsch PA, Marincola FM, Filie A, Hijazi YM, Kleiner DE, Abati A,. Melanoma-associated antigen recognized by T cells (MART-1). The advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration. Cancer 1999; 87: 37-42.
18. Ordonez NG, Ji XL, Hickey RC,. Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma. Am J Clin Pathol 1988; 90: 385-390.
19. Fetsch PA, Marincola FM, Abati A,. Cytokeratin positivity in fine-needle aspirates of metastatic malignant melanoma: Fact or fiction? Diagn Cytopathol 1999; 20: 393-396.
20. Argenyi ZB, Cain C, Bromley C, et al. S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study. Am J Dermatopathol 1994; 16: 233-240.
21. Skelton HG, Maceira J, Smith KJ, et al. HMB45 negative spindle cell malignant melanoma. Am J Dermatopathol 1997; 19: 580-584.
22. Xu X, Chu AY, Pasha TL, Elder DE, Zhang PJ,. Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas. Am J Surg Pathol 2002; 26: 82-87.
23. Hisaoka M, Ishida T, Kuo TT, et al. Clear cell sarcoma of soft tissue: A clinicopathologic, immunohistochemical, and molecular analysis of 33 cases. Am J Surg Pathol 2008; 32: 452-460.
24. Martignoni G, Pea M, Reghellin D, Zamboni G, Bonetti F,. PEComas: The past, the present and the future. Virchows Arch 2008; 452: 119-132.
25. Fetsch PA, Fetsch JF, Marincola FM, Travis W, Batts KP, Abati A,. Comparison of melanoma antigen recognized by T cells (MART-1) to HMB-45: additional evidence to support a common lineage for angiomyolipoma, lymphangiomyomatosis, and clear cell sugar tumor. Mod Pathol 1998; 11: 699-703.
26. Yan S, Brennick JB,. False-positive rate of the immunoperoxidase stains for MART1/MelanA in lymph nodes. Am J Surg Pathol 2004; 28: 596-600.